# OnCo record gim-122 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/gim-122/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "gim-122" ;
  schema:name "GIM-122"@en ;
  schema:alternateName "GIM122"@en ;
  schema:description "GIM-122 is an experimental humanised IgG1 kappa dual-functioning monoclonal antibody from Georgiamune, in phase 1 trials for advanced solid malignancies."@en ;
  schema:url <https://onco.cc/drugs/gim-122/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.georgiamune.com/pipeline>, <https://clinicaltrials.gov/study/NCT06028074>, <https://clinicaltrials.gov/search?intr=GIM-122> ;
  onco:status "phase-1" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Humanised IgG1 kappa dual-functioning monoclonal antibody" ;
  onco:cancers <https://onco.cc/cancers/metastatic-cancer/> ;
  onco:companies <https://onco.cc/companies/georgiamune/> ;
  onco:trials <https://onco.cc/trials/nct06028074/> .